Page 73 - MEMORIA ANUAL 2019 SEHH-FEHH

Programa EsPañol dE TraTamiEnTos En HEmaTología (PETHEma)
MEMORIA ANUAL 2019
SOCIEDAD ESPAÑOLA FUNDACIÓN ESPAÑOLA
DE HEMATOLOGÍA Y HEMOTERAPIA DE HEMATOLOGÍA Y HEMOTERAPIA
Belhadj K, Lahuerta JJ, Garelik MB, Bladé J, Moreau P, Attal M. Integrated Analysis of Bortezomib-Lenalidomide-Dexamethasone vs Bortezomib-Thalidomide-Dexa- methasone in Transplant-Eligible Newly Diagnosed Myeloma. 17th International Myeloma Workshop. Boston, Sep 12-15, 2019. Clin Lymphoma Myeloma. 2019;19(10 Suppl):E1-E2. Abstract: OAB-001. Doi: https://doi.org/10.1016/j.clml.2019.09.002.
• Medina A, Jiménez C, Puig N, Flores-Montero J, Paiva B, Sarasquete ME, Prieto- Conde I, García-Álvarez M, Chillón C, Alcoceba M, González-Calle V, Gutiérrez NC, de Arriba F, Hernández MT, Bladé J, Martínez-López J, Calasanz MJ, Lahuerta JJ, Mateos MV, San-Miguel J, González M, García-Sanz R. Prognostic implications of MRD assessment in multiple myeloma patients: comparison of Next-Generation Sequencing and Next-Generation Flow. 17th International Myeloma Workshop. Bos- ton, Sep 12-15, 2019. Clin Lymphoma Myeloma. 2019;19(10 Suppl):E47. Abstract: OAB-070. Doi: https://doi.org/10.1016/j.clml.2019.09.071.
• Garcés JJ, Bretones G, Burgos L, Valdés-Mas R, Alignani D, Álvarez Puente D, Goi- coechea I, García-Álvarez M, Garate S, Rodríguez I, Calasanz MJ, Rodríguez-Otero P, Ríos Tamayo R, Martínez-López J, Millacoy P, Palomera Bernal L, Del Orbe R, Pérez Montaña A, Agirre X, Flores-Montero J, Sanoja-Flores L, Orfao A, El Omri H, Prosper F, López-Otín C, San-Miguel J, Paiva B. Circulating Tumor Cells (CTCs) for Com- prehensive and Multiregional Non-Invasive Genetic Characterization of Multiple Myeloma (MM). 17th International Myeloma Workshop. Boston, Sep 12-15, 2019. Clin Lymphoma Myeloma. 2019;19(10 Suppl):E351. Abstract: OAB-84. Doi: https:// doi.org/10.1016/j.clml.2019.09.580.
• Sanz MA. Current treatment of acute promyelocytic leukemia. 10th Eurasian Hematology Oncology Congress. Istanbul, Turkey. Oct 08-11, 2019. Leuk Res. 2019;85(Suppl 1):S20. Abstract: SP-01.
• Rocchi S, Goldschmidt H, Rosinol L, Pantani L, Zweegman S, Salwender HJ, La- huerta JJ, Lokhorst HM, Petrucci MT, Blau I, Oriol A, Testoni N, Weisel K, Ríos R, Patri- arca F, Blanchard J, Dozza L, Mateos MV, Galli M, San-Miguel JF, Boccadoro M, Bladé J, Sonneveld P, Cavo M. Double vs single autologous stem cell transplantation for newly diagnosed multiple myeloma: long-term follow up (10-years) analysis of randomized phase 3 studies. 47th Congress of the Italian-Society-of-Hematology. Rome, Oct 07-09, 2019). Haematologica. 2019;104(Suppl 2):9. Abstract: C006.
• Ribera JP, Morgades M, Ciudad J, Montesinos P, Barba P, García-Cadenas I, Mo- reno MJ, Vives S, Esteve J, Gil C, Monsalvo S, Artola MT, Ribera J, Genescà E,
73